Small caps in Canada, especially in tech, are full of faux-companies. You know, the kind where the problem being solved isn’t really a problem, and the “technology” being advertised is actually five years old.
PredictMedix (PMED.C) isn’t one of them.
The last time I wrote about PredictMedix, I made an argument about:
- The resilience of pharmaceuticals as a sector, and
- The scalability of the tech, and hence the business